Top SitesXencor | Designing Proteins Delivering Medicines™

Machine Readiness

Stored receipt and evidence

Overall

20

Readable

65

Callable

0

Commerce

0

Payment

0

Machine Access

Inspect the site's MCP endpoint

Open MCP explorer

DialtoneApp can scan the stored discovery files for this domain, try the MCP initialize handshake, and show the raw protocol transcript.

Purchase boundary

read only

Control boundary

unknown

Payment rails

None

Payment providers

None

Payment methods

None

Payment protocols

None

Payment assets

None

Payment networks

None

Capabilities

None

Verified payment surface

No

Crypto only

No

Readable docs

robots, llms

Products

0

Variants

0

Priced variants

0

Currencies

0

Offers

0

Priced offers

0

Priced actions

0

Samples

Offer samples

No stored offer samples.

Samples

Action samples

No stored action samples.

Samples

Product samples

No stored product samples.

Document

robots.txt

Open robots.txt
User-agent: Scrapy
Allow: /

# Default Flywheel robots file
User-agent: *
Disallow: /calendar/action:posterboard/
Disallow: /calendar/action:agenda/
Disallow: /calendar/action:oneday/
Disallow: /calendar/action:month/
Disallow: /calendar/action:week/
Disallow: /calendar/action:map/
Disallow: /calendar/action~posterboard/
Disallow: /calendar/action~agenda/
Disallow: /calendar/action~oneday/
Disallow: /calendar/action~month/
Disallow: /calendar/action~week/
Disallow: /calendar/action~stream/
Disallow: /events/action~posterboard/
Disallow: /events/action~agenda/
Disallow: /events/action~oneday/
Disallow: /events/action~month/
Disallow: /events/action~week/
Disallow: /events/action~stream/

Document

llms.txt

Open llms.txt
Generated by All in One SEO v4.9.1, this is an llms.txt file, used by LLMs to index the site.

# Xencor

Proteins By Design

## Sitemaps

- [XML Sitemap](https://xencor.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Pages

- [Home](https://xencor.com/)
- [Opportunities](https://xencor.com/careers/opportunities/)
- [Publications](https://xencor.com/publications/)
- [Opportunities](https://xencor.com/careers/opportunities-2/)
- [Contact Us](https://xencor.com/contact-us/)
- [Pipeline](https://xencor.com/pipeline/) - [/av_codeblock] [/av_section] [av_heading tag='h4' padding='20' heading='CONTACT US' color='' style='blockquote modern-quote' custom_font='' size='25' subheading_active='' subheading_size='15' custom_class='' admin_preview_bg='' av-desktop-hide='' av-medium-hide='' av-small-hide='' av-mini-hide='' av-medium-font-size-title='' av-small-font-size-title='' av-mini-font-size-title=''
- [XmAb657](https://xencor.com/pipeline/xmab657/)
- [Clinical Trials](https://xencor.com/clinical-trials/)
- [Plamotamab](https://xencor.com/pipeline/plamotamab/)
- [XmAb942](https://xencor.com/pipeline/xmab942/)
- [XmAb541](https://xencor.com/pipeline/xmab541/)
- [XmAb819](https://xencor.com/pipeline/xmab819/)
- [Privacy Policy](https://xencor.com/privacy-policy/)
- [About Us](https://xencor.com/about-us/)
- [XmAb808](https://xencor.com/pipeline/xmab808/)
- [Your California Privacy Rights](https://xencor.com/privacy-policy/your-california-privacy-rights/)
- [Technology](https://xencor.com/technology/)
- [Expanded Access Policy](https://xencor.com/clinical-trials/expanded-access-policy/)
- [Xtend Fc Domains](https://xencor.com/technology/xtend-fc-domains/)
- [Immune Inhibitor Fc Domains](https://xencor.com/technology/immune-inhibitor-fc-domains/)
- [Cytotoxic Fc Domains](https://xencor.com/technology/cytotoxic-fc-domains/)
- [Bispecific Fc Domains](https://xencor.com/technology/bispecific-fc-domains/)
- [Careers](https://xencor.com/careers/)

## Portfolio Items

- [Terrific bispecifics crash CAR T party: Watch data mature, says Xencor CEO](https://xencor.com/portfolio-item/bioworld-today-terrific-bispecifics-crash-car-t-party-watch-data-mature-says-xencor-ceo/)
- [Amgen And Xencor Announce Strategic Collaboration In Cancer Immunotherapy And Inflammation](https://xencor.com/portfolio-item/amgen-and-xencor-announce-strategic-collaboration-in-cancer-immunotherapy-and-inflammation/)
- [Xencor Announces Strategic Collaboration with Novartis for Bispecific Programs, including XmAb 14045 and XmAb 13676](https://xencor.com/portfolio-item/xencor-announces-strategic-collaboration-with-novartis-for-bispecific-programs-including-xmab-14045-and-xmab-13676/)

## Categories

- [Management](https://xencor.com/dvteamtaxonomy/management/)

## Portfolio Categories

- [featured](https://xencor.com/portfolio_entries/featured/)

Document

llms-full.txt

Not stored for this site.